Anal Cancer News
Anal Cancer News
Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (August 20, 2009)
The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in... Continue Reading
Latest Anal Cancer News By Stage
Screening/Prevention
Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (August 20, 2009)
The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in the Journal of the National Cancer Institute.[1] Human... Continue Reading
Women with CIN at Higher Risk for Anal Cancer and Other Cancers (March 22, 2007)Women with CIN at Higher Risk for Anal Cancer and Other Cancers According to an early online publication in Lancet Oncology, women diagnosed with cervical intraepithelial neoplasia (CIN) grade 3 are at an increased risk of developing vaginal, vulvar,... Continue Reading
New Colorectal Cancer Test Offers Hope for Early Detection (March 3, 2002)New Colorectal Cancer Test Offers Hope for Early Detection According to a report in the November issue of the journal Gastroenterology, early detection of colorectal cancer and precancerous tumors may be possible with a new screening test that... Continue Reading
Selenium May Reduce Risk of Developing Lung, Colorectal, and Prostate Cancers (March 3, 2002)Selenium May Reduce Risk of Developing Lung, Colorectal, and Prostate Cancers The essential dietary nutrient, selenium, may help reduce the risk of developing cancers of the lung, colon, rectum, and prostate, as well as reduce the number of deaths... Continue Reading
More Screening and PreventionStages I-II
No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)
No Benefit with Addition of Platinol® to Treatment for Anal Cancer Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published... Continue Reading
5-FU/Mitomycin Remains Standard of Care for Anal Cancer (July 26, 2006)5-FU/Mitomycin Remains Standard of Care for Anal Cancer According to results recently reported at the 2006 semi-annual meeting of the Radiation Therapy Oncology Group (RTOG), treatment including the chemotherapy agents 5-fluorouracil?and?mitomycin-C (Mutomycin?)... Continue Reading
Radiation to the Pelvis Increases Risk of Pelvic Fractures (November 28, 2005)Radiation to the Pelvis Increases Risk of Pelvic Fractures According to a recent article published in the Journal of the American Medical Association (JAMA), women who undergo radiation to the pelvis for cancers of the cervix, rectum, or anus are at an... Continue Reading
Intensive Chemotherapy and Radiation Therapy Combo May Improve Outcomes for Persons with Cancer of the Anus (February 4, 2002)Intensive Chemotherapy and Radiation Therapy Combo May Improve Outcomes for Persons with Cancer of the Anus Persons who have cancers of the anus that have spread to the nearby lymph nodes or are large in size may require more aggressive therapy than... Continue Reading
Treatment of Anal Cancer: Protective Drug, Called Amifostine, Reduces the Side Effects of Chemotherapy and Radiation Therapy (February 3, 2002)Treatment of Anal Cancer: Protective Drug, Called Amifostine, Reduces the Side Effects of Chemotherapy and Radiation Therapy The side effects of chemotherapy and radiation therapy as treatment for anal cancer may be reduced with the use of a drug called... Continue Reading
More Stages I-IIStages IV
No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)
No Benefit with Addition of Platinol® to Treatment for Anal Cancer Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published... Continue Reading
5-FU/Mitomycin Remains Standard of Care for Anal Cancer (July 26, 2006)5-FU/Mitomycin Remains Standard of Care for Anal Cancer According to results recently reported at the 2006 semi-annual meeting of the Radiation Therapy Oncology Group (RTOG), treatment including the chemotherapy agents 5-fluorouracil?and?mitomycin-C (Mutomycin?)... Continue Reading
Treatment of Anal Cancer: Protective Drug, Called Amifostine, Reduces the Side Effects of Chemotherapy and Radiation Therapy (February 3, 2002)Treatment of Anal Cancer: Protective Drug, Called Amifostine, Reduces the Side Effects of Chemotherapy and Radiation Therapy The side effects of chemotherapy and radiation therapy as treatment for anal cancer may be reduced with the use of a drug called... Continue Reading
More Stage IVRecurrent
Surgical Salvage Therapy is Effective Treatment for Patients with Rectal Cancer that Relapse Locally after Initial Sphincter-Conserving Treatment (February 4, 2002)
Surgical Salvage Therapy is Effective Treatment for Patients with Rectal Cancer that Relapse Locally after Initial Sphincter-Conserving Treatment The standard of care for most patients with anal cancer is now initial treatment with radiation or chemoradiotherapy,... Continue Reading
More Recurrent
